Dingell Backs Sunscreen TEA Reform As Sun Sets On His Career
This article was originally published in The Rose Sheet
Executive Summary
The longest-serving member of Congress says he is committed to working with members of both parties to approve the Sunscreen Innovation Act so it can be signed into law this year. The bill would impose tight deadlines on FDA’s review of TEA applications for sunscreen ingredients, eight of which are pending currently.
You may also be interested in...
EWG Seeks Realistic FDA Review Deadlines In Sunscreen Innovation Act
While the Environmental Working Group supports the Sunscreen Innovation Act, it would like to see realistic deadlines put in place to accelerate FDA’s review of sunscreen-ingredient time-and-extent applications without including a default mechanism that would grant free market access to certain sunscreen actives when FDA fails to act within allotted timeframes.
FDA Sunscreen Decision Deadlines, Expedited TEAs Proposed
The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.
MHRA on herbals
"Using Herbal Medicines: Advice to Consumers" is a new guidance document issued July 27 that informs consumers about how to avoid low-quality products on the market, the UK's Medicines & Healthcare products Regulatory Agency announces. The document warns that "any medicine - herbal or otherwise - has the potential to have adverse effects," and states that the safe use of herbals "has not been established" in pregnant women, breastfeeding mothers, children or the elderly. MHRA also explains that products bearing a PL (product license) or THR (Traditional Herbal Registration) symbol on their product labels are regulated by the government, while products with no symbols have not been assessed by the agency. The guidance is being issued in the wake of MHRA's efforts to remove a number of questionable products from the market, including Real Herbs' supplement that was advertised to "inhibit the growth of tumor" and Rena Chinese Medical Center's capsule that claimed to have "strong effects in controlling HIV"...